Exosens
EXENS | XPAR
Overview
Corporate Details
- ISIN(s):
- FR001400Q9V2
- LEI:
- 969500R3AKTPEDO9EG76
- Country:
- France
- Address:
- 18 AVENUE PYTHAGORE, 33700 MERIGNAC
- Website:
- http://www.exosens.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Exosens is an innovative company specializing in the development and commercialization of advanced sensor technologies and environmental monitoring solutions. Headquartered in Grenoble, France, Exosens is at the forefront of creating cutting-edge products that address the critical needs of industries and communities for accurate, reliable, and real-time data on environmental conditions. The core mission of Exosens is to harness the power of sensor technology to enhance environmental awareness and sustainability. By providing high-precision sensors and comprehensive monitoring systems, Exosens aims to help organizations and individuals make informed decisions that promote environmental protection and improve quality of life.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-13 11:03 |
Declaration of Voting Results & Voting Rights Announcements
Franchissements de seuils et déclaration d'intention
|
French | 128.8 KB | |
| 2025-05-02 15:19 |
Regulatory News Service
Franchissement de seuils
|
French | 115.1 KB | |
| 2025-04-30 18:00 |
General Meeting Notice
Exosens: Availability of documents and information relating to the Combined Gen…
|
English | 190.8 KB | |
| 2025-04-30 18:00 |
General Meeting Notice
Exosens : Mise à disposition des documents et renseignements relatifs à l’Assem…
|
French | 177.9 KB | |
| 2025-04-30 17:45 |
Report Publication Announcement
Exosens: Availability of 2024 Universal Registration Document
|
English | 144.5 KB | |
| 2025-04-30 17:45 |
Report Publication Announcement
Exosens : Mise à disposition du Document d’enregistrement universel 2024
|
French | 149.9 KB | |
| 2025-04-29 18:44 |
Annual Report (ESEF)
DOCUMENT D'ENREGISTREMENT UNIVERSEL
|
French | 24.9 MB | |
| 2025-04-29 14:17 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
|
French | 115.8 KB | |
| 2025-04-28 07:30 |
Earnings Release
Exosens enregistre une forte croissance de son chiffre d'affaires au T1 2025 da…
|
French | 289.2 KB | |
| 2025-04-28 07:30 |
Earnings Release
Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market e…
|
English | 277.3 KB | |
| 2025-04-22 14:36 |
Major Shareholding Notification
Franchissements de seuils
|
French | 119.2 KB | |
| 2025-03-20 07:30 |
Regulatory News Service
EXOSENS INTÈGRE L’INDICE SBF 120
|
French | 165.6 KB | |
| 2025-03-20 07:30 |
Regulatory News Service
EXOSENS JOINS THE SBF 120 INDEX
|
English | 156.9 KB | |
| 2025-03-03 07:31 |
Regulatory News Service
Exosens réalise son premier investissement de capacité de production en vision …
|
French | 253.2 KB | |
| 2025-03-03 07:31 |
Regulatory News Service
Exosens makes first US investment in night vision production capacity to addres…
|
English | 204.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |